نتائج البحث - Chris Mitchell

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe

    Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe حسب Amrana Qureshi, Chris Mitchell, Sue Richards, Ajay Vora, Nick Goulden

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003

    Efficacy and toxicity of a paediatric protocol in teenagers and young adults with Philadelphia chromosome negative acute lymphoblastic leukaemia: results from UKALL 2003 حسب Rachael Hough, Clare Rowntree, Nick Goulden, Chris Mitchell, Anthony V. Moorman, Rachel Wade, Ajay Vora

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

    Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial حسب Ajay Vora, Nick Goulden, Rachel Wade, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Sue Richards

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial

    Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymp... حسب Ajay Vora, Nick Goulden, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Anthony V. Moorman, Rachel Wade

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    A national study into the rural and remote pharmacist workforce

    A national study into the rural and remote pharmacist workforce حسب Janie Smith, Col White, Louise Roufeil, Craig Veitch, Lisa Pont, Bhavini Patel, Kristine Battye, Karen Luetsch, Chris Mitchell

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003

    Outcome for children and young people with <scp>E</scp>arly <scp>T</scp>‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, <scp>UKALL</scp> 2003 حسب Katharine Patrick, Rachel Wade, Nick Goulden, Chris Mitchell, Anthony V. Moorman, Clare Rowntree, Sarah Jenkinson, Rachael Hough, Ajay Vora

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia

    Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia حسب Christoph Lutz, Petter Woll, Georgina Hall, Anders Castor, Hélène Dreau, Giovanni Cazzaniga, Jan Zuna, C. E. Jensen, Sally A. Clark, Andrea Biondi, Chris Mitchell, Helen Ferry, Anna Schuh, Veronica J. Buckle, Sten Eirik W. Jacobsen, Tariq Enver

    منشور في 2012
    احصل على النص الكامل
    Carta
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: